(19)
(11) EP 1 280 822 A2

(12)

(88) Date of publication A3:
27.06.2002

(43) Date of publication:
05.02.2003 Bulletin 2003/06

(21) Application number: 01929598.9

(22) Date of filing: 24.04.2001
(51) International Patent Classification (IPC)7C07K 14/47, A61K 48/00, C12N 15/87
(86) International application number:
PCT/EP0104/621
(87) International publication number:
WO 0108/1370 (01.11.2001 Gazette 2001/44)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 24.04.2000 US 199153 P

(71) Applicants:
  • Novartis AG
    4002 Basel (CH)

    BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

    AT 
  • The Scripps Research Institute
    La Jolla, CA 92037 (US)

(72) Inventors:
  • BALICKI, Danuta
    Montreal, Quebec H2W 1T8 (CA)
  • BEUTLER, Ernest
    La Jolla, CA 92037 (US)

(74) Representative: Gros, Florent 
Novartis AG
4002 Basel
4002 Basel (CH)

   


(54) HISTONE H2A-DERIVED PEPTIDES USEFUL IN GENE DELIVERY